abcnews - A federal appeals court has restricted access to one of the most common means of abortion in the U.S. by blocking the mailing of mifepristone
AI Summary: A federal appeals court has imposed new limits on distribution of mifepristone, blocking mail-order shipments and narrowing telehealth-based prescribing. The decision immediately complicates access for patients and clinicians who rely on remote care and pharmacy delivery, forcing last‑minute logistical changes, increased travel, and swift legal and policy responses as providers scramble to adapt.
FDA updates mifepristone safety review, but pharmacies remain reluctant / 4 months
Telehealth abortion pills rise as teens drive online demand / 5 months
Supreme Court preserves telehealth and mail access to abortion pill / 3 months
HHS decertifies Kentucky organ procurement group Network for Hope / 24 days
Court blocks new restrictions on abortion pill, upholding FDA standards / 5 wks
FDA weighs easing access to compounded peptides for patients / 4 months
Abortion‑pill bans won’t stop telehealth access, providers say / 2 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.